OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
The current therapeutic approach for anaemia after kidney transplant	26
Do not forget about transplant patients during disasters	25
Dual organ transplantation: Pancreas and Liver in the kidney axis	23
The clinical application of frailty in nephrology and transplantation	23
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	21
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	20
WNK1 in the kidney	18
Recent advances in dialysis membranes	17
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	17
Novel therapeutic and diagnostic approaches for preeclampsia	16
Urinary extracellular vesicles: does cargo reflect tissue?	15
Coronavirus disease 2019, vitamin D and kidney function	15
The lupus nephritis classification: lost in translation	13
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	13
KCa3.1 in diabetic kidney disease	12
Chronic kidney disease with unknown cause across the global spectrum	11
Current approaches to overcome recurrent focal segmental glomerulosclerosis after kidney transplantation	11
Uromodulin: more than a marker for chronic kidney disease progression	11
Updates in hypertension: new trials, targets and ways of measuring blood pressure	11
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	11
Lipid management to mitigate poorer postkidney transplant outcomes	11
Serum creatinine and serum cystatin C as an index of muscle mass in adults	10
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	10
Editorial introductions	10
Role of NCC in the pathophysiology of hypertension in primary aldosteronism	10

Non calcium phosphate binders - Is there any evidence of benefit	10
COVID-19 in patients with glomerular disease	10
Maximizing opportunities for kidney transplantation in older adults	9
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	9
Electrolytes disturbances in cancer patients	9
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	9
Bone loss and kidney stone risk in weightlessness	9
SNF472: mechanism of action and results from clinical trials	9
Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice	9
The genetic spectrum of Gitelman(-like) syndromes	9
Climate change and kidney health: an urgent call to action	8
APOL1 nephropathy – a population genetics success story	8
Editorial introductions	8
Editorial introductions	8
Deep learning applications for kidney histology analysis	8
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	8
Interferon gamma in the pathogenesis of hypertension − recent insights	8
Editorial introductions	8
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder	7
Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection	7
Clearing the air: a review of the effects of air pollution on dialysis outcomes	7
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	7
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	7
Recent advances in the understanding of the peritoneal membrane	6
Lysine and salt-sensitive hypertension	6
Revisiting the relationship between (Pro)Renin receptor and the intrarenal RAS: focus on the soluble receptor	6
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease	6
The role of calprotectin in vascular calcification	6
Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients	6
Automation and innovation in home hemodialysis machines	6
Finerenone: a new mineralocorticoid receptor antagonist to beat chronic kidney disease	6
Contribution of phosphate and FGF23 to CKD progression	6
Rethinking arterial hypertension: the need for a paradigm shift	6
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	6
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	6
HIV-associated kidney disease: the changing spectrum and treatment priorities	6
Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension	6
How to assess quality of life in persons with chronic kidney disease	6
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	6
Impact of intensive blood pressure control on kidney outcomes	6
Climate change and its influence in nephron mass	5
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	5
Ageing, cellular senescence and chronic kidney disease: experimental evidence	5
Assessment of microcirculatory function during hemodialysis	5
Blood pressure targets in chronic kidney disease: still no consensus	5
Hypernatremia in the intensive care unit	5
Prediction models for earlier stages of chronic kidney disease	5
The role of hypoxia in chronic kidney disease: a nuanced perspective	5
Optimizing kidney and cardiovascular protection in an era of multiple effective treatments	5
Treatment options for managing obesity in chronic kidney disease	5

Renal denervation for the treatment of hypertension and kidney disease	5
The K–Cl cotransporter-3 in the mammalian kidney	5
New insights into renal calcium-sensing receptor activation	5
Interleukin-15 in kidney disease and therapeutics	5
Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney disease	5
Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population	5
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship	5
Editorial introductions	5
Aldosterone-independent regulation of K+ secretion in the distal nephron	4
Mechanisms of leptin-induced endothelial dysfunction	4
Efficacy and safety of Sodium-Glucose-Transporter-2 inhibitors in kidney transplant patients	4
Antineutrophil cytoplasmic antibody-associated vasculitis	4
Editorial introductions	4
International equity in access to home dialysis	4
Predictive models in chronic kidney disease: essential tools in clinical practice	4
Editorial introductions	4
Editorial introductions	4
Updated diagnostic and therapeutic management for membranous nephropathy	4
Novel indications for referral and care for simultaneous liver kidney transplant recipients	4
Editorial introduction	4
Cellular therapies in kidney transplantation	4
Prospects for gene therapy in polycystic kidney disease	4
Editorial introduction	4
The role of claudins in renal transepithelial transport and kidney disease	4
New therapies for immunoglobulin A nephropathy: what's the standard of care in 2023?	4